SMU1 Knockdown抑制胃癌的生长,迁移和入侵,并调节细胞循环
Meirui Qian1, Xue Liang1, Qingmei Zeng1,2
1Department of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an, China.
Cancer control : journal of the Moffitt Cancer Center
|September 5, 2024
概括
在胃癌 (GC) 中,SMU1被上调,通过增强细胞增殖和迁移,促进瘤的进展. SMU1可以作为GC的预后标志物,提供新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 已知SMU1在DNA复制和RNA剪接中的作用,但其在胃癌 (GC) 中的特定功能尚不清楚.
- 研究SMU1在GC中的致癌作用对于开发新的治疗和诊断方法至关重要.
研究的目的:
- 阐明胃癌中SMU1的功能和失调机制.
- 评估SMU1作为GC中的癌症驱动因素和预后标记物的潜力.
主要方法:
- 使用TCGA和GEO数据库分析了GC与正常组织中的SMU1表达.
- 在277个GC组织样本上进行了免疫组织化学.
- 进行了体外和体内测试,以评估SMU1对GC细胞增殖,入侵和迁移的影响.
主要成果:
- 在GC组织中,SMU1mRNA和蛋白质水平显著上调.
- 高SMU1表达与GC预后差相关,是独立的预后因素.
- 升高的SMU1增强了GC细胞的增殖,入侵和迁移;通过调节G1/S细胞周期检查点,SMU1抑制阻碍了GC的进展.
结论:
- SMU1通过通过细胞周期激活影响细胞增殖,作为GC进展的预后标志物.
- 结果为GC的理解,诊断和管理提供了洞察力.
更多相关视频
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


